The US Food and Drug Administration (FDA) will start accepting applications for the new PreCheck scheme that will streamline ...

AstraZeneca has returned to CSPC with a licensing deal for the Chinese company’s monthly injectables for obesity.

Sanofi's sales grew 9.9% YoY – driven by a diverse range of portfolio classics and new launches across immunology, oncology and rare disease.

Repertoire Immune Medicines has collaborated with Eli Lilly for the development of tolerising therapies to treat several autoimmune diseases.

IQVIA has announced a strategic, long-term partnership with Boehringer Ingelheim focused on strengthening data capabilities across therapeutic areas.

Roche’s adjusted operating profit rose by a lower-than-expected 5% in 2025, due to the weakened US dollar, despite the ...

The US Food and Drug Administration (FDA) has accepted for priority review Otsuka Pharmaceutical’s new drug application (NDA) ...

Insilico Medicine has entered a strategic partnership with Qilu Pharmaceutical and its subsidiary Shanghai Qilu ...

The FDA has granted breakthrough therapy designation to Biogen’s litifilimab for CLE, a chronic autoimmune skin condition.

This year, sales of Eliquis (apixaban) are projected to decline by 15.2% due to the loss of its European market exclusivity ...

Lilly and German biotech Seamless Therapeutics will develop recombinase-based treatments for hearing loss. In a move that ...